CU20170088A7 - Formulaciones inyectables de paracetamol - Google Patents
Formulaciones inyectables de paracetamolInfo
- Publication number
- CU20170088A7 CU20170088A7 CUP2017000088A CU20170088A CU20170088A7 CU 20170088 A7 CU20170088 A7 CU 20170088A7 CU P2017000088 A CUP2017000088 A CU P2017000088A CU 20170088 A CU20170088 A CU 20170088A CU 20170088 A7 CU20170088 A7 CU 20170088A7
- Authority
- CU
- Cuba
- Prior art keywords
- paracetamol
- injectable formulations
- administration
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 3
- 229960005489 paracetamol Drugs 0.000 title abstract 3
- 239000007972 injectable composition Substances 0.000 title abstract 2
- 238000001990 intravenous administration Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000010790 dilution Methods 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000010253 intravenous injection Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000001297 phlebitis Diseases 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
<p>La presente invención se refiere a inyecciones intravenosas de bajo volumen de paracetamol o su sal farmaceuticamente aceptable y el método de preparación del mismo. Las formulaciones proporcionan una alta concentración de paracetamol o su sal farmacéuticamente aceptable en un sistema disolvente de Ia presente invención que puede administrarse no sólo a través de Ia vía de infusión intramuscular e intravenosa, sino también para Ia administración de bolo IV Iento después de Ia dilución con fluidos acuosos hasta el volumen final de no más de 20 ml. Estas formulaciones inyectables permanecen estables y también son adecuadas para administración a través de una vía intravenosa lenta con efectos secundarios minimizados (tales como flebitis, dolor, etc.)<br /> </p>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN4102MU2014 | 2014-12-20 | ||
| PCT/IB2015/058876 WO2016097899A1 (en) | 2014-12-20 | 2015-11-17 | Injectable formulations of paracetamol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20170088A7 true CU20170088A7 (es) | 2018-03-13 |
Family
ID=55022620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CUP2017000088A CU20170088A7 (es) | 2014-12-20 | 2015-11-17 | Formulaciones inyectables de paracetamol |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20180000940A1 (es) |
| EP (1) | EP3233055B1 (es) |
| JP (1) | JP2017538762A (es) |
| KR (1) | KR20170099911A (es) |
| CN (1) | CN107205924A (es) |
| AR (1) | AR103188A1 (es) |
| AU (1) | AU2015365533A1 (es) |
| BR (1) | BR112017012975B1 (es) |
| CA (1) | CA2969303A1 (es) |
| CL (1) | CL2017001629A1 (es) |
| CO (1) | CO2017006268A2 (es) |
| CU (1) | CU20170088A7 (es) |
| DO (1) | DOP2017000134A (es) |
| EA (1) | EA201791409A1 (es) |
| EC (1) | ECSP17038668A (es) |
| ES (1) | ES3009433T3 (es) |
| HU (1) | HUE070091T2 (es) |
| IL (1) | IL252729A0 (es) |
| JO (1) | JO3689B1 (es) |
| MA (1) | MA40599A1 (es) |
| MD (1) | MD20170071A2 (es) |
| MX (1) | MX383557B (es) |
| MY (1) | MY203965A (es) |
| PE (1) | PE20171305A1 (es) |
| PH (1) | PH12017501005B1 (es) |
| PL (1) | PL3233055T3 (es) |
| SG (1) | SG11201704435PA (es) |
| TN (1) | TN2017000232A1 (es) |
| TW (1) | TWI649097B (es) |
| UA (1) | UA122136C2 (es) |
| UY (1) | UY36466A (es) |
| WO (1) | WO2016097899A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107229455B (zh) | 2016-03-24 | 2019-09-17 | 阿里巴巴集团控股有限公司 | 一种业务处理方法、装置及系统 |
| GR1011104B (el) * | 2024-12-18 | 2026-01-16 | Ιουλια Τσετη | Προγεμισμενη συριγγα υδατικου διαλυματος παρακεταμολης καταλληλη για ενεσιμη χορηγηση |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2751875B1 (fr) | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
| IT1301976B1 (it) * | 1998-07-31 | 2000-07-20 | Angelini Ricerche Spa | Composizione farmaceutica iniettabile a base di paracetamolo |
| IT1313579B1 (it) | 1999-07-30 | 2002-09-09 | Acraf | Composizione farmaceutica liquida a base di paracetamolo. |
| ITMI20012135A1 (it) | 2001-10-16 | 2003-04-16 | Bioren S A | Soluzioni iniettabili pronte all'uso di paracetamolo |
| KR20080016689A (ko) * | 2005-05-27 | 2008-02-21 | 파나세아 바이오테크 리미티드 | 약물주사가 가능한 새로운 형태의 조성물 및 이러한조성물을 위한 조제방법 |
| DK1973527T3 (da) * | 2005-12-15 | 2010-02-01 | Acusphere Inc | Fremgangsmåder til fremstilling af partikelbaserede farmaceutiske formulationer til parenteral indgivelse |
| WO2009047634A2 (en) | 2007-06-18 | 2009-04-16 | Combino Pharm, S.L. | Aqueous formulations of acetaminophen for injection |
| EP2307056B1 (en) | 2008-01-17 | 2021-12-15 | Pharmis Biofarmacêutica, LDA | Stabilized aqueous formulation containing paracetamol |
| MX2011003695A (es) * | 2008-10-09 | 2011-08-17 | A F S P A Aziende Chimiche Riunite Angelini Francesco A C R | Formulacion farmaceutica liquida con contenido de paracetamol. |
| BR112012031928B1 (pt) * | 2010-06-30 | 2021-08-31 | Troikaa Pharmaceuticals Ltd | Composições farmacêuticas as quais incluem paracetamol e processo para preparação do mesmo |
| TWI577377B (zh) * | 2010-09-16 | 2017-04-11 | Ｖｉｉｖ醫療保健公司 | 醫藥組合物 |
| CN102258485A (zh) * | 2011-01-11 | 2011-11-30 | 北京润德康医药技术有限公司 | 一种含对乙酰氨基酚的注射用制剂及其应用 |
| CN102600068A (zh) * | 2011-01-24 | 2012-07-25 | 联康药业克雷恩特塞提斯制药实验室有限责任公司 | 稳定即用的可注射扑热息痛制剂 |
-
2015
- 2015-11-17 MA MA40599A patent/MA40599A1/fr unknown
- 2015-11-17 PL PL15816228.9T patent/PL3233055T3/pl unknown
- 2015-11-17 TN TN2017000232A patent/TN2017000232A1/en unknown
- 2015-11-17 SG SG11201704435PA patent/SG11201704435PA/en unknown
- 2015-11-17 MD MDA20170071A patent/MD20170071A2/ro not_active Application Discontinuation
- 2015-11-17 MX MX2017008264A patent/MX383557B/es unknown
- 2015-11-17 EA EA201791409A patent/EA201791409A1/ru unknown
- 2015-11-17 BR BR112017012975-2A patent/BR112017012975B1/pt active IP Right Grant
- 2015-11-17 ES ES15816228T patent/ES3009433T3/es active Active
- 2015-11-17 EP EP15816228.9A patent/EP3233055B1/en active Active
- 2015-11-17 US US15/537,642 patent/US20180000940A1/en not_active Abandoned
- 2015-11-17 PH PH1/2017/501005A patent/PH12017501005B1/en unknown
- 2015-11-17 UA UAA201706668A patent/UA122136C2/uk unknown
- 2015-11-17 WO PCT/IB2015/058876 patent/WO2016097899A1/en not_active Ceased
- 2015-11-17 CU CUP2017000088A patent/CU20170088A7/es unknown
- 2015-11-17 CA CA2969303A patent/CA2969303A1/en not_active Abandoned
- 2015-11-17 KR KR1020177017759A patent/KR20170099911A/ko not_active Ceased
- 2015-11-17 HU HUE15816228A patent/HUE070091T2/hu unknown
- 2015-11-17 AU AU2015365533A patent/AU2015365533A1/en not_active Abandoned
- 2015-11-17 CN CN201580069391.5A patent/CN107205924A/zh active Pending
- 2015-11-17 MY MYPI2017701979A patent/MY203965A/en unknown
- 2015-11-17 PE PE2017001066A patent/PE20171305A1/es unknown
- 2015-11-17 JP JP2017533277A patent/JP2017538762A/ja active Pending
- 2015-11-27 TW TW104139783A patent/TWI649097B/zh not_active IP Right Cessation
- 2015-12-09 JO JOP/2015/0303A patent/JO3689B1/ar active
- 2015-12-21 AR ARP150104211A patent/AR103188A1/es unknown
- 2015-12-21 UY UY0001036466A patent/UY36466A/es unknown
-
2017
- 2017-06-06 IL IL252729A patent/IL252729A0/en unknown
- 2017-06-09 DO DO2017000134A patent/DOP2017000134A/es unknown
- 2017-06-20 CL CL2017001629A patent/CL2017001629A1/es unknown
- 2017-06-20 EC ECIEPI201738668A patent/ECSP17038668A/es unknown
- 2017-06-23 CO CONC2017/0006268A patent/CO2017006268A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202303593B (en) | Liquid protein formulations containing viscosity-lowering agents | |
| AR107014A1 (es) | Formulación farmacéutica acuosa | |
| CL2019002190A1 (es) | Reducción de la viscosidad de formulaciones farmacéuticas que comprende una proteína terapéutica a una concentración de al menos 70 mg/ml, donde la proteína terapéutica no es un anticuerpo (divisional solicitud 201700984) | |
| MX2015012559A (es) | Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson. | |
| EA033373B1 (ru) | Композиции на водной основе, предварительно наполненный шприц, их применения и способ доставки гипофукозилированного или нефукозилированного антитела против baffr млекопитающему | |
| PE20160681A1 (es) | Formulacion de premezcla de dexmedetomidina | |
| CL2017001629A1 (es) | Formulaciones inyectables de paracetamol. | |
| PE20170426A1 (es) | Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo | |
| PY1916802A (es) | Formulaciones inyectables de paracetamol | |
| UA115333C2 (uk) | Склад есмололу для парентерального введення | |
| EA201391512A1 (ru) | Твердая фармацевтическая композиция | |
| MX372644B (es) | Una combinacion de unidades de dosificacion para su uso en el tratamiento del parto prematuro. | |
| HK1226310A1 (en) | Liquid protein formulations containing water soluble organic dyes | |
| RU2013143983A (ru) | Способ коррекции иммунной недостаточности у инфицированного вирусом лейкоза крупного рогатого скота | |
| RU2014142874A (ru) | Способ лечения похмельного синдрома у лиц, не относящихся к больным алкоголизмом | |
| TH154084A (th) | สารละลายอะเซทามิโนเฟนที่ฉีดได้สำหรับการให้ทางไขสันหลัง | |
| AR091633A1 (es) | Solucion inyectable de acetaminofen para su administracion por via espinal |